Introduction
Norpseudoephedrine (NPE) and norephedrine (NE) belong to the amphetamine family of ephedra alkaloids and can be found in plants like Khat (Catha edulis) 1, 2 and in some Ephedra species 3 . In the human body they are known to have sympathomimetic function 4 and act as non-selective adrenergic receptor agonists and norepinephrine re-uptake inhibitors 5 . As pharmaceuticals, they have been used to induce mydriasis (dilation of pupils), to stabilize blood pressure, as nasal decongestants, appetite suppressants, and in cold/flu medication. [6] [7] [8] [9] In most countries N(P)Es are available only on prescription. 10 On the German market cathine ((1S,2S)-NPE) is currently sold for its appetite suppressant function as an active ingredient in ALVALIN ®11, 12 . In addition to the pharmacological interest, the four N(P)Es stereoisomers are valuable synthons, ligands, and chiral auxiliaries in organic syntheses. 13, 14 Indeed, a SciFinder ® search revealed that N(P)Es have been used as reactants in >5000 different reactions. 15 Currently >350 different synthetic strategies towards N(P)E stereoisomers have been described in SciFinder ® . 15 Still, ethods for the asymmetric synthesis of nor(pseudo)ephedrines from inexpensive starting materials are rare and require either multistep preparative routes, are based on relatively expensive reagents or lack high enantio-and diastereomeric selectivities. 16 Single enzymatic steps [17] [18] [19] [20] and enzyme cascades [21] [22] [23] [24] [25] have significant potential in chiral asymmetric synthesis. If a suitable multi-step cascade is performed in one pot, it can be a highly selective, step-and atom efficient strategy, which circumvents time consuming and expensive isolation of intermediates. 26, 27 For the synthesis of (1R,2R)-norpseudoephedrine and (1S,2R)norephedrine we recently described a 1-pot 2-step enzyme cascade with overall conversions of up to >95 %. The combination of a highly (R)-selective carboligase with either an (S)-or (R)-selective -transaminase (TA) gave access to these products in high optical purities of ee >99 % and de >98 %. 28 However, synthesis of the two remaining stereoisomers (1S,2S)-NPE and (1R,2S)-NE requires a highly (S)-selective thiamine diphosphate (ThDP)-dependent carboligase in the first reaction step (Scheme 1-A), which is currently not available among known wild-type enzymes. Due to our knowledge of the reaction mechanism and factors influencing chemo-and stereoselectivities of ThDP-dependent enzymes, a variant has been designed of the pyruvate decarboxylase from Acetobacter pasteurianus, producing phenylacetylcarbinol (PAC) (S)-selectively for the first time. 29 Here, we describe the evaluation of this enzyme for the analogous 1-pot 2-step synthesis of (1S,2R)-NE and (1S,2S)-NPE. To avoid a chiral purification step of the resulting nor(pseudo)ephedrine diastereomers, an alternative synthetic strategy ('TA-ADH', scheme 1-B) was investigated. Starting from 1-phenylpropane-1,2-dione (1,2-PPDO), in principle all four N(P)E isomers should be accessible in two steps by combining respective stereoselective -TAs in the first with alcohol dehydrogenases (ADHs) in the second cascade step. We here discuss advantages and bottlenecks of both strategies.
Synthesis strategy A: carboligase-TA

A-1: (1R,2R)-NPE -high space-time-yields using benzaldehyde emulsions
To date, the biocatalytic 2-step synthesis of (1R,2R)NPE (Scheme 2) was only performed in aqueous buffer with low substrate concentrations (maximum of 20 mM benzaldehyde) with space-time-yields (STY) of ~2 g l -1 d -1 . 28 To increase the productivity of this cascade, the enzyme concentration was optimized and its performance in the presence of higher benzaldehyde concentrations was investigated (up to 100 mM benzaldehyde). The 2-step cascade, a combination of the AHAS-I from E. coli and the (R)-selective TA from Aspergillus terreus (At-(R)TA) for the synthesis of (1R,2R)-NPE, could be performed in one pot. 28 Starting from equimolar concentrations of pyruvate and benzaldehyde (10 mM each) in the carboligation step, the reductive amination could be performed in an optimized manner with a 5-fold excess of D-alanine as cosubstrate. This one pot approach is feasible without addition of further compounds or enzymes, despite the low equilibrium constant of the reductive amination (K eq = 2.31·10 -3 ), because AHAS-I removes the co-product pyruvate by converting it to acetolactate and thus shifts the equilibrium to the product side. 28 Although the cascade could be performed in a simultaneous mode (both enzymes added simultaneously), the sequential mode (TA added after the AHAS-I reaction was completed) proved to be advantageous due to a lower byproduct formation (benzylamine, formed by reductive amination of benzaldehyde). 28 In order to further optimize the biocatalytic approach, the minimum amount of enzymes required for a reaction containing 20 mM benzaldehyde, 20 mM pyruvate, and 100 mM D-alanine (see Fig. 1 ) was determined. It was found that 0.5 mg mL -1 AHAS-I and 0.4 mg mL -1 At-(R)TA were sufficient to achieve 95 % conversion of 20 mM benzaldehyde within 13.5 h ( Fig. 1 ). This corresponds to a space-time yield of ~5 g l -1 d -1 over both reaction steps. To enhance the reaction efficiency further, the initial benzaldehyde (BA) and pyruvate concentration was increased to 25, 50, 75 and 100 mM but using a constant 5-fold excess of alanine. In line with the optimized reaction parameters, per mmol benzaldehyde 0.025 mg mL -1 AHAS-I (90 min reaction time) and 0.02 mg mL -1 At-(R)TA (12 h reaction time) were added. Although benzaldehyde is not soluble in aqueous buffer >50 mM, in all cases conversions of up to 90 % were observed with less than 5 % benzylamine by-product formation (Fig. 2) . Interestingly, this emulsion system did not significantly influence the reaction performance. In line with this data, finally space-time-yields up to26 g l -1 d -1 (1R,2R)-NPE were achieved starting from 100 mM benzaldehyde and 90 % conversion could be observed within 13.5 h. 
A-2: (1R,2S)-NEapplication of lyophilized whole cells
The use of whole cells can reduce catalyst costs by a factor of 10 and is particularly advantageous if side reactions do not occur. 30 For an economically feasible large scale application, access to (1R,2S)-NPE has been demonstrated by a combination of AHAS-I and Cv-(S)TA (Scheme 3). 28 Here, the use of enzymes as lyophilized whole cells without enzyme purification was investigated, which features the benefit of easy handling compared to wet cells (e.g. in terms of weighing out small quantities). Concerning the first step, purified AHAS-I shows a high initial rate activity of ~1.8 U mg -1 protein for the catalyzed carboligation of benzaldehyde and (decarboxylated) pyruvate, which is within the range of industrially suitable catalysts 17 ( Fig. 3 -A). The use of 5 mg mL -1 of lyophilized recombinant E. coli whole cells (LWC) yielded a similar reaction velocity under equivalent reaction conditions ( Fig. 3-B ), which is a consequence of the lower protein amount per mg catalyst .(see SDS-PAGE ESI (Electronic Supplementary Information)- Figure 1 ). In both cases a complete conversion of 10 mM benzaldehyde was achieved within ~0.5 h. This corresponds to a STY of ~72 g l -1 d -1 and a specific STY (STY g catalyst -1 ) for LWC of ~14 g l -1 d -1 g LWC -1 and for purified enzyme of ~72 g l - Additionally, a comparison of LWC and purified enzymes for the second reductive amination step of (R)-PAC using the Cv-(S)TA was investigated. In a first trial with L-alanine as amine donor no NPE product formation was observed (data not shown). However, exchange of L-alanine by (S)-methylbenzylamine ((S)--MBA) in a reaction containing 10 mM (R)-PAC and 5 mg mL -1 LWC, resulted in a conversion of 85 % (see Fig. 4 ). Notably, we observed a lag phase of 60 min before product formation started when the reductive amination step was catalyzed with lyophilized whole cells ( Figure 4 ). This seems to be caused by membrane required rehydration time of the lyophilized whole cells in the aqueous buffer and could be reduced by a pre-incubation of the LWC in reaction buffer ((see ESI chapter 3.1.4). Still, the reaction rate with 5 mg mL -1 LWC was almost as fast as with 1 mg mL -1 purified enzyme. In both cases a conversion of ~85 % was reached within 3 h, which corresponds to a STY of ~10 g l -1 d -1 . According to this, the calculated specific STY for LWC is ~2 g l -1 d -1 g LWC -1 and for purified enzyme ~10 g l -1 d -1 g enzyme -1 .
Figure 4
Cv-(S)TA catalyzed reductive amination of 10 mM (R)-PAC in the presence of 10 mM (S)-α-MBA catalyzed by either purified enzyme (1 mg mL -1 ) or lyophilized cells (5 mg mL -1 ).
The application of lyophilized whole cells in general was found to be suitable for the "carboligase-TA" cascade. This is of special interest for a reaction process, since overall process costs are reduced when enzyme purification can be avoided. Compared to a similar reaction with lyophilized enzymes, the catalysts cost can be significantly lowered by a factor of 10, as was suggested by a general estimation for catalyst cost by Tufvesson and co-workers. 30
A-3, A-4: Access to (1S,2R)-NE and (1S,2S)-NPE
The most promising enzyme for (S)-selective carboligation of benzaldehyde and acetaldehyde is ApPDC-E469G. 29, 31 Although the stereoselectivity for (S)-PAC of 89 % ee is not optimal, the 2-step cascade in combination either with an (S)-or (R)-selective ω-TA would result in the formation of (1S,2S)-NPE (Scheme 4; A-3) or (1S,2R)-NE (Scheme 4; A-4). The missing influence of the chiral vicinal hydroxyl group on the TA reactivity is in line with data for a similar substrate (1,3dihydroxy-1-phenylpropane-2-one) published earlier. 33 To further increase the optical purities of the N(P)E in our synthetic cascade approach, a catalyst with higher stereoselectivity for the (S)-PAC synthesis would be required. Since so far further rational design attempts were not successful, the combination of ω-TA with oxidoreductases (synthesis strategy B) was subsequently investigated to access these two products with higher optical purities.
Synthesis strategy B: TA-ADH
A novel reaction cascade consisting of a TA in the first step and an ADH in the second step could circumvent the low optical purity in the "carboligase-TA" cascade for the synthesis of (1S,2R)-NE and (1S,2S)-NPE. Using 1-phenylpropane-1,2-dione (1,2-PPDO) as substrate, the combination of an (S)selective TA (here Cv-(S)TA) either with the (R)-selective ADH from Ralstonia spec. (RADH) or the (S)-selective ADH from Lactobacillus brevis (LbADH) could give access to (1R,2S)-NE and (1S,2S)-NPE (strategy B-1; Scheme 5). Since the enzymes for both steps are highly selective for arylaliphatic substrates, as was earlier demonstrated for oxidoreductases 34 and ω-TAs 28 , the products should be accessible in high optical purity. To complete the strategies towards all possible stereoisomers of N(P)E with high stereoselectivities, the access to (1S,2R)-NE and (1R,2R)-NPE was investigated by a combination of the (R)-selective At-(R)TA with LBADH and RADH, respectively (strategy B-2; scheme 5). Finally, the application of different enzyme preparations (lyophilized whole cells, purified enzymes or crude cell extract) was compared. In order to determine optimal reaction conditions for the reductive amination of 1,2-PPDO, reactions with lyophilized whole cells (LWC) containing Cv-(S)TA and different concentrations of the amine donor (S)--MBA were investigated and applied to the reductive amination with At-(R)TA (see ESI). A concentration of 15 mM (S)--MBA was sufficient to achieve full conversion of 10 mM 1,2-PPDO with Cv-(S)TA in 48 h. With higher concentrations of the amine donor (S)--MBA the acetophenone concentration (co-product formed upon deamination of (S)--MBA) did not increase to more than 10 mM indicating that the theoretically possible diamination of the diketone 1,2-PPDO did not occur. This is in accordance to previous results in which the reductive amination of aryl-aliphatic ketones can only be achieved if the aliphatic group is not larger than an ethyl group. 35 The initial rate activity for the reductive amination of 1,2-PPDO towards (S)-APPO was ~0.005 U mg -1 LWC with LWC containing overexpressed Cv-(S)TA or ~0.008 U mg -1 protein with purified Cv-(S)TA (see ESI; 1 U corresponds to the amount of enzyme that catalyzes the conversion of 1 µmol min -1 1,2-PPDO under standard conditions). In contrast to this, in a reaction with E. coli crude cell extract containing At-(R)TA (scheme 5 B-1) a significantly higher activity of ~0.1 U mg -1 protein was measured for the synthesis of (R)-APPO. Here, in all cases a complete conversion of the diketone substrate was observed in only 3 h (see ESI).
The subsequent reduction reaction of the intermediate product APPO can in principle be performed in the same pot without intermediate isolation. The required cofactor NADPH (0.5 mM) was regenerated by the addition of formate dehydrogenase (FDH) from Pseudomonas spec. and sodium formate, based upon a method described previously. 36 When the cascade was performed in the sequential mode without quenching the TA reaction, 1-phenylpropane-1,2-diol was detected as by-product. This was most likely due to the reversibility of the TA reaction and an equilibrium that favoured the di-reduction of PPDO by ADH. To suppress the diol formation, inactivation of the TA after the first reaction step was investigated. Either a pH-shift (pH 7.5 to pH 2 with 20 % (v/v) HCland re-titration to pH 7.5 with 1 M NaOH) or an ultrafiltration step to remove the TA was tested. Using inactivation by pH-shift, the combination Cv-(S)TA/LbADH as purified enzymes gave an overall conversion of 80 % after 52 h. With this biocatalytic cascade the product (1S,2S)-NPE was accessible for the first time with high optical purity: de >99 % and ee >98 % (Tab. 1; entry #2). When ultrafiltration was used to remove the TA for the combination of Cv-(S)TA/LbADH with purified enzymes, the 2-step conversion was significantly lower (57 % after 60 h), but ee and de remained equally high (Tab. 1; entry #2 compared to 4). The same trend was found for the combination of Cv-(S)TA/RADH with purified enzymes, were the product (1R,2S)-NE was accessible with ee >98 % and de >95 % (Tab. 1; entry #3). Here, the 2-step cascade with an ultrafiltration step after the TA reaction resulted in an overall conversion of 55 %, whereas 82 % conversion to (1R,2S)-NE was achieved using the pH-shift for TA inactivation (Tab. 1; entry #3 compared to 5). Possible explanations for the reduced yields upon ultrafiltration might be that centrifugation was carried out in plastic ware (all other steps were performed in closed glass vials) and evaporation and adsorption of the intermediate might lower the final yield significantly. However, this was not investigated in detail because the cheaper pH-shift method solved the problem.
Compared to the excellent optical purity of (1S,2S)-NPE obtained in the 2-step reaction with purified enzymes (see above), the biotransformations using lyophilized whole cells yielded products with decreased optical purities (Tab. 1; entry #8,9): Cv-(S)TA/LbADH ((1S,2S)-NPE: ee >92 %, de 90 %) and Cv-(S)TA/RADH ((1R,2S)-NE: ee >99 %, dr ~8:2). Here, a decrease in optical purity might be caused by the isomerization of (S)-APPO, induced by other E. coli enzymes. Although, it was not possible to measure the ee for the intermediate product APPO, this isomerization could lead to a decrease of the de for the N(P)E products even if both cascade enzymes (ADH and TA) are highly selective.
Similar results were obtained when crude cell extract containing At-(S)TA was used for the reductive amination step. In combination with RADH (purified enzyme) high conversions (>90 %) but rather low optical purities ((1R,2R)-NPE: ee >99 %, de >55 %) were detected (Tab. 1; entry #7). Moreover, the combination At-(R)TA/LbADH did not result in (1S,2R)-NE as the major product, but gave (1S,2S)-NPE (Tab. 1; entry #6,10). As mentioned for the cascades with Cv-(S)TA lyophilized whole cells, an isomerization of APPO could lead to a decrease in de values even if the enzymes applied are highly selective.
As a consequence, purified enzymes rather than whole cells or crude cell extracts are the method of choice for the TA/ADH reaction cascade. As shown for the combination Cv-(S)TA/LbADH, (1S,2S)-NPE is accessible in high optical purities (>99 % de, >98 % ee) when purified enzymes are used in both reaction steps (Tab. 1; entry #4).
Conclusions
In summary, two biocatalytic cascade strategies have been developed for the synthesis of all four phenylpropanolamine stereoisomers and the use of inexpensive whole cells for the reaction steps has been investigated. In the "carboligase-TA" strategy, a combination of the (R)-selective AHAS-I from E. coli either with an (S)-or a (R)-selective -TA gave access to (1R,2S)-NE and (1R,2R)-NPE in high optical purities (ee >99 % and de >98 %). As a proof-of-principle we demonstrated that the synthesis of (1R,2R)-NPE could be performed with substrate concentrations of up to 100 mM by the combination AHAS-I/At-(R)TA. Space-time yields up to ~26 g l -1 d -1 were achievable. Moreover, the application of LWC is possible, but lead to a reduction in specific STY by a factor of 10 for the C-C coupling reactions and by a factor of 5 for the reductive transaminations. Since a highly (S)-selective enzyme for the synthesis of the intermediate (S)-PAC is currently not available, the products (1S,2R)-NE and (1S,2S)-NPE were only accessible in moderate optical purities using this strategy. An alternative 2-step synthesis strategy combining -TA with ADHs was evaluated to give access to all N(P)E isomers in higher optical purities. Indeed, the isomer (1S,2S)-NPE, also known as cathine, was synthesized enzymatically in high optical purities. Here, the combination of the (S)-selective TA Cv-(S)TA with the (S)-selective alcohol dehydrogenase LbADH gave (1S,2S)-NPE with an ee >98 % and a de >99 % when purified enzymes were used. This novel biocatalyic reaction cascade can be performed in one pot without isolation of intermediates. However, a deactivation of the -TA prior to the reductive hydrogenation was required. Although it was demonstrated that this reaction could could be carried out with cheaply produced lyophilized whole cells, there are two major drawbacks. On the one hand, the specific STYs are significantly lower with lyophilized whole cells, which partially negate the 10-fold lower catalyst production costs of cells. On the other hand, the optical purity of the product was higher with purified enzymes. Since chiral product purification methods a reaction conditions for reductive amination was carried out as indicated with purified enzyme (1 mgprotein mL -1 ), CCE (1 mgprotein mL -1 ) or LWC (10 mgLWC mL -1 ) of the respective transaminases (At-(R)TA or Cv-(S)TA) in 100 mM HEPES (pH 7.5), 200 µM PLP, with ~10 mM 1,2-PPDO (see Supp. Information) and 15 mM (R)-or respective (S)--MBA at a reaction temperature of 21 °C. As indicated (by joined columns: #2,3 -#4,5 -#6,7 -#8,9 and #10,11), the reaction solutions were split for the subsequent oxidoreduction step. b reactions were terminated either by ultrafiltration (membrane cut-off: 10 kDa), pH-shift (titrated with 20 % (v/v) HCl to pH 2 then re-titrated with 10 M NaOH to pH 7.5) or not terminated.
might dramatically increase production costs, the use of purified enzymes can be beneficial if the additional enzyme purification costs are below downstream processing costs. For industrial applications immobilization of enzymes might be a method to decrease production costs (e.g. in terms of downstream processing, recyclability) and in some cases immobilization results in an increased catalyst stability and/or activity. [37] [38] [39] [40] [41] [42] In general, it has been demonstrated that enzymes from different toolboxes can be efficiently combined yielding all stereoisomers of desired N(P)E. Here, the "TA-ADH" reaction cascade was developed as an alternative to the "carboligase-TA" cascade giving access to optically pure (1S,2S)-NPE in only two biocatalytic steps.
